What the research measured
4 university trial records across IL, OH in 2024. Yield was above the trial mean in 4 of 4 records with a reported yield and trial mean. Differences may reflect site and management conditions.
4 trial records · 1 season (2024) · IL, OH. 2 named locations in the loaded data.6 independent sources.What it is. A maturity group 3.8 Enlist E3 soybean, tolerant to 2,4-D choline, glyphosate and glufosinate, entered in the 2024 Illinois and Ohio State trials.
Study conditions and limitations
- Late-group placement. The fit is the central and southern Corn Belt, not the northern tier.
- Enlist E3 needs the matching herbicide program and stewardship.
- One season of public data so far.
Read the sources · 6
- Illinois Variety Testing: corn and soybean trials ↗
Replicated regional trials at two locations per region, published as tables of entry yield, moisture, lodging and the trial mean.
- Ohio Soybean Performance Trials 2024 ↗
Regional early and late maturity-group trials at two locations each, with yield and the trial mean.
- Illinois 2024 soybean trial table · IL · Region 3 ↗
77.8 bu/ac against a trial mean of 68.3; 19 entries in the trial.
- Illinois 2024 soybean trial table · IL · Region 4 ↗
68.4 bu/ac against a trial mean of 64.9; 14 entries in the trial.
- Ohio State 2024 soybean trial table · OH · Central Late ↗
77.2 bu/ac against a trial mean of 73.1; 57 entries in the trial.
- Ohio State 2024 soybean trial table · OH · South Late ↗
84.6 bu/ac against a trial mean of 76.8; 28 entries in the trial.
Before you buy, ask
- Which trials near my farm included this variety, and how did it finish against the trial mean there?
- What trait package and seed treatment are in the bag I would receive?
- How many seasons of public data exist for this variety in my maturity zone?
Record
- Sources checked
- Trial tables are read from the university trial database at request time. Program pages checked September 26, 2026.
- Company response
- None yet. Dyna-Gro Seed (Nutrien Ag Solutions) can send corrections, additional trials, or a statement; it is published here, labelled, and never edits the research summary. Send a correction →